Loading viewer...
report
Format: PDF report
This report presents interim results from an open-label extension study of Antolimab for treating Eosinophilic Gastritis and Duodenitis, highlighting its investigational status.
presentation
report
Snap
report
1st Mariner Bank
report
Aqua America
report
Borqs Technologies